Epha2 agonistic monoclonal antibodies and methods of use thereof

Details for Australian Patent Application No. 2009239780 (hide)

Owner Purdue Research Foundation MedImmune, LLC

Inventors Carles-Kinch, Kelly; Stewart, Jane C.; Kinch, Michael S.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009239780

Parent 2003276832

Filing date 24 November 2009

Wipo publication date 10 December 2009

Acceptance publication date 17 March 2011

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

10 December 2009 Application Open to Public Inspection

  Published as AU-B-2009239780

10 December 2009 Complete Application Filed

17 March 2011 Application Accepted

  Published as AU-B-2009239780

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009239783-Haemostatic material

2009239778-Pyrrole antifungal agents